Analysis and Suggestions on current situation of Chinese Drug Shortage Problem
DOI:
https://doi.org/10.54097/2g20np79Keywords:
Drug shortage, China, Analysis, Suggestions.Abstract
Medicines play an important role in protecting people's health, but drug shortage is a long-standing and complex problem in the world. As the world's second largest pharmaceutical market, China's drug shortage problem occurs frequently and requires a lot of research to be solved. This study uses the method of literature analysis to summarize the statistics, research and reports mainly from China on the domestic drug shortage problem. It is found that the main reasons for China's drug shortage are low drug profits, flawed centralized procurement policies, drug production capacity and insufficient development and inadequate supplement of APIs. According to this, this study also puts forward related suggestions including strengthening system construction, guaranteeing Supply and Strengthen Monitoring and improving the supply security of active pharmaceutical ingredients. This study enables other scholars to understand the situation of drug shortages in China, and also provide theoretical support for policy improvement and subsequent research.
Downloads
References
Sundus Shukar, Fatima Zahoor, Khezar Hayat, et al. Drug shortage: Causes, impact, and mitigation strategies. Frontiers in Pharmacology, 2021, 12.
Hu Anqi, Li Yong, Ma Aixia, et al. Investigation and Analysis of the Reasons for Drug Shortage from 26 Medical Institutions in China. China Pharmacy, 2017, 28 (27): 3754 - 3758.
Yang Caijun, Cai Wenfang, Li Zongjie, et al. The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians. PLOS ONE, 2018, 13 (10), e0205238.
Song Yinyin, Li Jianchun, Zhao Fei, Jin Pengfei. Drug shortages in China: a cross-sectional study. BMC Health Services Research, 2023, 23 (1).
Mao N, Zhou M, Yang, X. Current situation, causes, and solutions to drug shortage in China—A case study of Jiangsu Province. Value in Health, 2018, 21: S46 – S47.
Yin S, Yang P, Li X, et al. Combating drug shortages in China: surveillance warning and practice standardization. International Journal of Clinical Pharmacy, 2020, 42 (2): 309 – 314.
Yin Shi, Sun Shusen, Deng Jing, et al. Establishment and application of an index system for the risk of drug shortages in China: based on Delphi Method and analytic Hierarchy Process. International Journal of Health Policy and Management, 2022, 11: 2860 - 2868.
Dong Jie, Gao Yang, Liu Yi, Yang Xiuling. Development and validation of the nomogram to predict the risk of hospital drug shortages: A prediction model. PLOS ONE, 2023, 18 (4): e0284528.
Li Zhiqun, Xu Jindong, Tan Huifeng, et al. Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China. Human Vaccines & Immunotherapeutic, 2019, 16 (1): 76 – 79.
Wu Suhan, Luo Min, Zhang Jingxia, et al. Pharmaceutical Supply Chain in China: Pricing and Production Decisions with Price-Sensitive and Uncertain Demand. Sustainability, 2022, 14(13): 7551.
Wang Xiaojun. Analysis of the current situation of drug shortage under the supply chain and the countermeasures. Journal of Traditional Chinese Medicine Management, 2018, 15: 10 - 12.
Zhao Zhigang, Wang Liwen, Zhu Leting, Zhu Chuanjun. Analysis of shortage of medicines in16 hospitals from5 different regions. Pharmaceutical Care and Research, 2008, 04: 246 - 48.
Centralized Volume Purchasing: the Effect has Just Begun to Show. Ministry of Finance of the People’s Republic of China. http://www.mof.gov.cn/zhengwuxinxi/xinwenlianbo/beijingcaizhengxinxilianbo/202108/t20210831_3749392.htm, 2023 - 9 - 17.
Ren Yanan, Bao Han, Wang Wei, Ren Lei, Wang Yukun. On Current Situation of Drug Shortage in Several Provinces and Cities in China. Chinese Pharmaceutical Affairs, 2020, 34 (03): 175 - 282.
LI Dashuang, Yan Jianzhou, Bai Mingyu, LI Xinyu, Shao Rong. Research on the Supply Problems and Countermeasures of National Centralized Drug Procurement. Health Economics Research, 2022, 39 (06): 12 - 16.
National Medical Security Administration’s Reply to Recommendation No. 1680 of the Third Session of the 13th National People’s Congress. National Healthcare Security Administration. http://www.nhsa.gov.cn/art/2020/9/24/art_26_3648.html, 2023 - 9 - 13.
Wu Lina, Yang Caijun, Shen Qian, Chang Jie, Zhu Wenwen, Ye Dan, Lv Bing, Yang Shimin. A Review of Research on Drug Shortages in China. Chinese Pharmaceutical Affairs, 2016, 30 (05): 458 - 65.
Ma Liyun, Zhao Ying, Li Sen, Huang Pu. Statistical and Analysis of Drug Shortage in 52 Sentinel Hospitals in Hubei Province. China Pharmacist, 2020, 23 (05): 926 - 30.
Gong Ying. Research on generic drug supply risk and immune strategy under the bachground of centralized bulk-buying of drugs. Nanjing University of Traditional Chinese Medicine, 2023.
Mao Ningying, Yang Xiujuan, Li Jun. Analysis on the Causes and Countermeasures of Drug Shortage in China from The Perspective of Supply Chain Risk. Chinese Journal of Hospital Pharmacy, 2019, 39 (11): 1107 - 11.
Rong Faqiang. The Research on the optimization of Project Risk Management of new drug development in Q Company. Shanghai Foreign Languages University, 2023.
Zhang Liqing, Li Lei. Analyzing The Causes of Medicine Shortage in China and The Countermeasures of Supply Guarantee. Chinese Health Service Management, 2019, 36 (02): 113 - 15.
Zhu Yameng, Fu Hongpeng. Analysis and Reflection on the Current Situation of Drug Shortage in China. Health Economics Research, 2021, 38 (06): 59 - 62.
Cheng Wenwen, Yu Fei, Zhang Siyu, Zhu Liang. Research on the Construction of Risk Assessment Index System of Drug Supply Chain in Public Hospitals Based on Stakeholder Theory. Chinese Pharmaceutical Affairs, 2022, 36 (05): 593 - 602.
Protamine Sulfate. Baidu Baike. https: //baike.baidu.com/item/%E9%B1%BC%E7%B2%BE%E8%9B%8B%E7%99%BD%E7%A1%AB%E9%85%B8%E7%9B%90/19177763?fromModule=lemma_inlink, 2023-9-13.
Lin Yiling, Yang Liping. Anti-monopoly regulation of API industry abuse of dominant market position and its improvement. Journal of Nanjing University of Traditional Chinese Medicine (Social Science Edition), 2023, 24 (04): 239 - 47.
Tang Lifan. Analysis of drug shortage and countermeasures —— Take a public medical and health institution in southwest province as an example. Kunming University of Science and Technology, 2022.
Yao Qian, Li Xiang. Fines of Ten Million Cannot Stop the Monopoly of Pharmaceutical Companies. Beijing Business Daily, 2023 - 04 - 14 (003).
Huang Zhe, Shi Hui, Xu Fengxiang. Comparison and suggestions of drug shortage management between China and the United States. Journal of Shenyang Pharmaceutical University, 2021, 38 (12): 1339 - 45.
Huang Zhe, Shi Hui, Xu Fengxiang. Study on the Countermeasures of Drug Shortage in China. Journal of Shenyang Pharmaceutical University, 2021 – 09 - 39.
Gong Lina. Research on legal response to drug shortages in the United States. Nankai University, 2022.
Li Jing, Chen Hong, Jiang Hongli. Local practice progress and enlightenment of shortage drug supply guarantee. Chinese Health Resources, 2021, 24 (04): 472 - 75+87.
Li Yong, Sun Qi. Shortage Risk and Countermeasures of Drug Centralized Procurement. Chinese Health Economics, 2022, 41 (09): 19 - 22.
Fang Bing. Study on Prevention and Control Strategies of Drug Shortages. Zhengzhou University, 2022.
Huang Runqing. Investigation on the Current Situation of Drug Supply Guarantee in Yunnan Province and Construction of Monitoring and Early Warning Platform. Kunming Medical University, 2021.
Li Yunshi. A heavy blow against API monopoly. Faren Magazine, 2023 (06): 47 - 49.
Ma Liyun, Ma Yuanyuan, Wang Hanxiang, Zhao Ying, Li Sen, Huang Pu. Study on the Causes and Coping Strategies of Drug Shortage in Hubei Province. Medicine and Society, 2020, 33 (08): 34 - 38.
Lin Yongze. Analysis of API monopoly and the path of government regulation. Price Supervision and Anti-Monopoly in China, 2020, 12: 24 - 28.
Ma Fei. Over 300 million antitrust fine revealed, secret war on raw materials escalates [N]. Medical Economic News, 2023 - 06 - 01 (001).
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
